JNJ
JOHNSON&JOHNSON
Health Care·Pharmaceuticals·UNITED STATES
$275.23
MCap $663.3B
as of 2026-09-04
Total
B5w
Fund
D3w
Quant
A9w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
-0.17
Sentiment 69.8%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$275.23
Adaptive Mean
$276.17
-0.94 vs mean
Adaptive σ
2.75
MIDOS BB
$270.66 – $281.67
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
+0.10
ROE
25.7%
Z +0.69
Rev Gr
6.6%
Z -0.22
EPS Gr
-0.9%
Z +0.27
OPM Gr
0.1%
Z -0.40
FCF Yld
2.5%
Z +0.26
EPS Surp
0.0%
Z -0.08
EPS 3mo Δ
-13.4%
Z +0.17
Fwd P/E
22.36
Z —
PEGY
0.12
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
18.64
Q6M
9.07
Q12M
14.58
MA 30/100
1.079
Bullish (MA30 > MA100)
α (Jensen)
0.7686
β (12M)
-0.18
σ (12M)
0.190
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
68%
Q Percentile
100%
Divergence
-31.6
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
-1.1
RS Pctl
59%
RS Decile
D6
Persistence
5w
at grade B
Options / OI Analysis
as of 2026-09-04
OI Center
$253.07
-8.1% from spot
Max Pain
$270.00
PCR (OI)
0.77
neutral
Skew
-0.38
OI Composite
-1
neutral
Direction
strong_bearish